A Seamless Phase 2a/2b, Randomized, Double-Blind, Placebo- and Active-Controlled, Multiple-Arm, Multiple-Stage, Adaptative Study Evaluating the Efficacy and Safety of LAD191 in Adults With Moderate-to-Severe Hidradenitis Suppurativa.
Datos básicos
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
ALMIRALL S.A
Cita
A Seamless Phase 2a/2b, Randomized, Double-Blind, Placebo- and Active-Controlled, Multiple-Arm, Multiple-Stage, Adaptative Study Evaluating the Efficacy and Safety of LAD191 in Adults With Moderate-to-Severe Hidradenitis Suppurativa. (M-27134-10). ALMIRALL S.A. 2025IP:ANTONIO MARTORELL CALATAYUD.
Portal de investigación